178 related articles for article (PubMed ID: 24532969)
21. The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Patel NR; Cunoosamy DM; Fagerås M; Taib Z; Asimus S; Hegelund-Myrbäck T; Lundin S; Pardali K; Kurian N; Ersdal E; Kristensson C; Korsback K; Palmér R; Brown MN; Greenaway S; Siew L; Clarke GW; Rennard SI; Make BJ; Wise RA; Jansson P
Int J Chron Obstruct Pulmon Dis; 2018; 13():1009-1019. PubMed ID: 29628759
[TBL] [Abstract][Full Text] [Related]
22. Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.
Ishikawa N; Hattori N; Kohno N; Kobayashi A; Hayamizu T; Johnson M
Int J Chron Obstruct Pulmon Dis; 2015; 10():185-92. PubMed ID: 25670894
[TBL] [Abstract][Full Text] [Related]
23. A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease.
Wells JM; Jackson PL; Viera L; Bhatt SP; Gautney J; Handley G; King RW; Xu X; Gaggar A; Bailey WC; Dransfield MT; Blalock JE
Am J Respir Crit Care Med; 2015 Oct; 192(8):934-42. PubMed ID: 26151090
[TBL] [Abstract][Full Text] [Related]
24. COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species.
Simpson JL; Baines KJ; Horvat JC; Essilfie AT; Brown AC; Tooze M; McDonald VM; Gibson PG; Hansbro PM
Respirology; 2016 May; 21(4):697-704. PubMed ID: 26781464
[TBL] [Abstract][Full Text] [Related]
25. Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.
Sibila O; Garcia-Bellmunt L; Giner J; Rodrigo-Troyano A; Suarez-Cuartin G; Torrego A; Castillo D; Solanes I; Mateus EF; Vidal S; Sanchez-Reus F; Sala E; Cosio BG; Restrepo MI; Anzueto A; Chalmers JD; Plaza V
Ann Am Thorac Soc; 2016 May; 13(5):636-42. PubMed ID: 26882402
[TBL] [Abstract][Full Text] [Related]
26. Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD.
Hurst JR; Wilkinson TM; Perera WR; Donaldson GC; Wedzicha JA
Chest; 2005 Apr; 127(4):1219-26. PubMed ID: 15821198
[TBL] [Abstract][Full Text] [Related]
27. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.
Wilkinson TM; Patel IS; Wilks M; Donaldson GC; Wedzicha JA
Am J Respir Crit Care Med; 2003 Apr; 167(8):1090-5. PubMed ID: 12684248
[TBL] [Abstract][Full Text] [Related]
28. The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD.
Banerjee D; Khair OA; Honeybourne D
Respir Med; 2005 Feb; 99(2):208-15. PubMed ID: 15715188
[TBL] [Abstract][Full Text] [Related]
29. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
Mallia P; Webber J; Gill SK; Trujillo-Torralbo MB; Calderazzo MA; Finney L; Bakhsoliani E; Farne H; Singanayagam A; Footitt J; Hewitt R; Kebadze T; Aniscenko J; Padmanaban V; Molyneaux PL; Adcock IM; Barnes PJ; Ito K; Elkin SL; Kon OM; Cookson WO; Moffat MF; Johnston SL; Tregoning JS
J Allergy Clin Immunol; 2018 Sep; 142(3):815-823.e6. PubMed ID: 29310905
[TBL] [Abstract][Full Text] [Related]
30. Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.
Andelid K; Andersson A; Yoshihara S; Åhrén C; Jirholt P; Ekberg-Jansson A; Lindén A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1253-63. PubMed ID: 26170654
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD.
Contoli M; Pauletti A; Rossi MR; Spanevello A; Casolari P; Marcellini A; Forini G; Gnesini G; Marku B; Barnes N; Rizzi A; Curradi G; Caramori G; Morelli P; Papi A
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 28982774
[TBL] [Abstract][Full Text] [Related]
32. Clarithromycin targets neutrophilic airway inflammation in refractory asthma.
Simpson JL; Powell H; Boyle MJ; Scott RJ; Gibson PG
Am J Respir Crit Care Med; 2008 Jan; 177(2):148-55. PubMed ID: 17947611
[TBL] [Abstract][Full Text] [Related]
33. Blood and sputum eosinophils in COPD; relationship with bacterial load.
Kolsum U; Donaldson GC; Singh R; Barker BL; Gupta V; George L; Webb AJ; Thurston S; Brookes AJ; McHugh TD; Wedzicha JA; Brightling CE; Singh D
Respir Res; 2017 May; 18(1):88. PubMed ID: 28482840
[TBL] [Abstract][Full Text] [Related]
34. Small airways dysfunction and neutrophilic inflammation in bronchial biopsies and BAL in COPD.
Lapperre TS; Willems LN; Timens W; Rabe KF; Hiemstra PS; Postma DS; Sterk PJ
Chest; 2007 Jan; 131(1):53-9. PubMed ID: 17218556
[TBL] [Abstract][Full Text] [Related]
35. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.
Hill AT; Campbell EJ; Hill SL; Bayley DL; Stockley RA
Am J Med; 2000 Sep; 109(4):288-95. PubMed ID: 10996579
[TBL] [Abstract][Full Text] [Related]
36. Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism.
Maneechotesuwan K; Kasetsinsombat K; Wongkajornsilp A; Barnes PJ
Respir Res; 2016 Aug; 17(1):104. PubMed ID: 27557561
[TBL] [Abstract][Full Text] [Related]
37. Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.
Thulborn SJ; Dilpazir M; Haldar K; Mistry V; Brightling CE; Barer MR; Bafadhel M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1199-1205. PubMed ID: 28458531
[TBL] [Abstract][Full Text] [Related]
38. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial.
Zu Y; Li D; Lei X; Zhang H
Trials; 2019 Nov; 20(1):647. PubMed ID: 31775843
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
40. Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD.
Pant S; Walters EH; Griffiths A; Wood-Baker R; Johns DP; Reid DW
Respirology; 2009 May; 14(4):495-503. PubMed ID: 19645868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
